|Bid||0.3400 x 4000|
|Ask||0.3640 x 7200|
|Day's Range||0.2820 - 0.3800|
|52 Week Range||0.2500 - 6.4000|
|PE Ratio (TTM)||-0.05|
|Earnings Date||Aug 21, 2017 - Aug 25, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
-Company to Host Business Update Conference Call and Webcast on August 23, 2017- LOS ANGELES , Aug. 14, 2017 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ...
NEW YORK, NY / ACCESSWIRE / July 19, 2017 / Capricor Therapeutics was a big winner in trading on Tuesday with shares seeing gains of over 100%. The company announced that its drug candidate for the treatment ...
LOS ANGELES, July 18, 2017 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the pricing of an underwritten public offering of 5,000 shares of its Series B 8% Mandatorily Convertible Preferred Stock ("Preferred Stock") and related warrants ("Warrants") to purchase up to 9,000 shares of Preferred Stock, at a public offering price of $1,000 per share of Preferred Stock and related Warrants, for gross proceeds of approximately $5 million, excluding the proceeds, if any, from the exercise of the Warrants.